ArticleIndian journal of ophthalmology2026
Plasma ablation versus super pulse CO2 laser ablation for treatment of benign eyelid margin lesions.
Article in Indian journal of ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo compare the outcomes of plasma ablation and super pulse CO2 laser ablation for treatment of benign eyelid margin lesions.
designRetrospective nonrandomized comparative study.
methodsSetting: institutional. STUDY POPULATION: Thirty-eight adults with unilateral clinically benign eyelid margin lesions were nonrandomly divided into two groups based on the treatment method. Lesions <10 mm and stable for at least 6 months were included. Lesions >10 mm, suspected premalignant or malignant lesions, and patients with active systemic disease were excluded. INTERVENTION PROCEDURES: Group 1: plasma ablation, Group 2: super pulse CO2 laser ablation.
main outcome measurespostoperative pain, time to wound epithelialization, postoperative complications and recurrence, and patient satisfaction.
resultsGroup 1 included 20 lesions, and Group 2 included 18 lesions. The mean size of the lesions was 5.7 ± 1.7 mm and 6.2 ± 1.8 mm, respectively ( P = 0.336). There was a highly significant difference between the two groups as regards mean time to wound epithelialization (9.1 ± 2.4 days in group 1 versus 21.1 ± 4.3 days in group 2, P < 0.001). Longer epithelialization time was associated with significantly greater pain ( P = 0.002). In group 2, transient hypopigmentation occurred in 2 (11.1%) patients and maldirection of eyelashes in 1 (5.6%). No recurrence was observed in either group. All (100%) patients of group 1 and 88.9% of group 2 were completely satisfied.
conclusionBoth plasma ablation and super pulse CO2 laser ablation are effective in the treatment of benign eyelid margin lesions with good cosmetic outcomes. The choice of the procedure should be individualized according to the patient's general condition, needs, and lesion characteristics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.